Cargando…
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association for the Study of Intestinal Diseases
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478752/ https://www.ncbi.nlm.nih.gov/pubmed/28670224 http://dx.doi.org/10.5217/ir.2017.15.3.263 |
| _version_ | 1783245016210079744 |
|---|---|
| author | Park, Jihye Cheon, Jae Hee |
| author_facet | Park, Jihye Cheon, Jae Hee |
| author_sort | Park, Jihye |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5478752 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54787522017-07-01 Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? Park, Jihye Cheon, Jae Hee Intest Res Editorial Korean Association for the Study of Intestinal Diseases 2017-07 2017-06-12 /pmc/articles/PMC5478752/ /pubmed/28670224 http://dx.doi.org/10.5217/ir.2017.15.3.263 Text en © Copyright 2017. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Park, Jihye Cheon, Jae Hee Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title | Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title_full | Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title_fullStr | Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title_full_unstemmed | Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title_short | Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
| title_sort | could adalimumab be used safely and effectively in intestinal behçet's disease refractory to conventional therapy? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478752/ https://www.ncbi.nlm.nih.gov/pubmed/28670224 http://dx.doi.org/10.5217/ir.2017.15.3.263 |
| work_keys_str_mv | AT parkjihye couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy AT cheonjaehee couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy |